Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.0070 USD
Change Today 0.00 / 0.00%
Volume 0.0
PGUZ On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 07/22/15 All times are local (Market data is delayed by at least 15 minutes).

pegasus pharmaceuticals inc (PGUZ) Snapshot

Open
$0.0070
Previous Close
$0.0070
Day High
$0.0070
Day Low
$0.0070
52 Week High
08/12/14 - $0.04
52 Week Low
06/17/15 - $0.0060
Market Cap
--
Average Volume 10 Days
500.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PEGASUS PHARMACEUTICALS INC (PGUZ)

Related News

No related news articles were found.

pegasus pharmaceuticals inc (PGUZ) Related Businessweek News

No Related Businessweek News Found

pegasus pharmaceuticals inc (PGUZ) Details

Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies. The company offers HeartVue 6S System, which is a screening tool used to diagnose heart and other cardiac diseases. It serves cardiologists, general practitioners, physicians, intensive care units, hospitals, emergency rooms, clinics, fitness facilities, sports teams, and other emergency medical facilities. Pegasus Pharmaceuticals Inc. was founded in 1995 and is headquartered in Palm Beach Gardens, Florida.

Founded in 1995

pegasus pharmaceuticals inc (PGUZ) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

pegasus pharmaceuticals inc (PGUZ) Key Developments

Pegasus Pharmaceuticals Develops Natural All-Purpose Cleaner/Degreaser

Pegasus Pharmaceuticals has developed natural all-purpose cleaner/degreaser. The all-natural formula has been created from biodegradable and naturally occurring compounds or derivatives. The product is water based and is environmentally friendly. It cleans and protects all types of surfaces. The natural formula may be utilized safely in any home, school, hospital or commercial environment.

Pegasus Pharmaceuticals Develops and Completes Testing of MoldGuardian a New Anti-Fungi Product

Pegasus Pharmaceuticals's MoldGuardian has been developed using 'Quality by Design' approach to create a protective barrier on any surface to eliminate the ability of mold spores to penetrate the pores and for any spores existing on a surface to grow. Also, MoldGuardian(TM) repels moisture which is an absolute necessity for mold growth. Thus, any spore sitting on a surface or in a pore will not grow without humidity. MoldGuardian(TM) was designed with mold spores in mind and to provide a long lasting prophylactic, protective barrier effect. MoldGuardian(TM) is formulated with ingredients that are hydrophobic, polyunsaturated and/or saturated hydrocarbons and their esters and alcohol derivatives as well as water insoluble antioxidants and water insoluble and/or very low water soluble vitamins. In the product all of the ingredients are emulsified in the aqueous solution and exist in the form of the stable emulsion. When MoldGuardian(TM) is applied on the surface and solution is dried, the emulsion is disintegrated and the dried ingredients create a thin layer on the surface penetrating into the material pores and provides a treated surface covered with protective layer. This layer is maintained by means of hydrophobic Van-Der-Waal's, dipole-dipole, and other non-covalent binding of hydrophobic ingredients with each other creating a protective barrier. It protects the surface from penetration and growth of fungi. This Water-resistant barrier protects the surface from fungal spores and/or cells penetration into the material surface and pores. It, also, prevents the passage of water even after long or continuous exposure to moisture. In addition water-resistant properties of the product have created conditions where moisture required for the fungal spore growth cannot penetrate through the barrier. MoldGuardian(TM) treated surfaces are deprived of the required moisture content and this prohibits surface growth when protected with the MoldGuardian(TM) product. Another feature is that the mold spores remain on the surface and do not spread to grow on another surface. When used on a preventive or regular basis it greatly reduces time, labor, liability and other expenditures. MoldGuardian(TM) helps to eliminate mold growth using naturally occurring compounds and neutral pH. The formula is comprised of a unique combination of non-toxic, biodegradable ingredients.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PGUZ:US $0.01 USD 0.00

PGUZ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PGUZ.
View Industry Companies
 

Industry Analysis

PGUZ

Industry Average

Valuation PGUZ Industry Range
No financial data is available for PGUZ.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PEGASUS PHARMACEUTICALS INC, please visit www.pegasusbiosciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.